Creation Of Such Libraries Relies On The Current Focus Of Research

By:


Drug design and discovery does not happen by chance but is a process of active searching by individual scientists. Often a template molecule (of proven biological activity) will be taken and systematically altered in small ways to generate whole series of structurally related compounds. These compounds can then be either tested against the original target disease or screened against a panel of diseases to find those molecules which processes biological activity. This process is extremely labor intensive and any means by which the cost of the search or the testing for activity can reduced is actively sort. A compound library is such a labor reducing facility [1]. A simple library will consist of information regarding properties of a number of compounds; this could include such things as structure, physical properties, chemical properties, purities or even synthesis patterns. A more complex library could be would consists if small amounts of actual compounds in known concentrations accompanied by all the known physical and chemical properties. This type library can be for the high through put screening for compounds of interest, whether they be of biological importance or synthetic chemical importance [2]. The key point of any library is the number and purity of the compounds contained within it. These could run into thousands of individual molecules. Obviously this approach means that a chemical library is a valuable item and many types of chemical libraries can be found commercially. Typical examples of the available library are epigenetics libraries, known biological active molecules library or even a natural product extracts library. The concept of a compound library is flexible in its design and structure; it can be adapted to virtually any series of chemicals, molecules or proteins that a researcher requires in course of his/her work, be that medical or industrial.

Compound libraries: Creation

One of the oldest compound libraries known is the Treatise of medical diagnosis and prognoses discovered in a series of ancient tablets dating back to the Mesopotamian period. These tablets not only contain medical information on treatment but the synthesis routes to formulate the medicine. More up-to-date than this is the Beilstein database which contains listings for over 9.5 million compounds gleaned from literature since 1771 [3]. However, these sort of libraries are great for reference but do not assist the researcher in his/her quest to find either the perfect catalyst or the one molecule that cures a disease. Smaller more specific libraries have generated which contain in addition to the standard structural, physical and chemical information but a dissolved sample of the actual compound itself [4-9]. Creation of such libraries relies on the current focus of research, since these focused libraries tend to be commercial products, the number of compounds in such libraries tend to be below 200 making their use manageable and relevant [2;10-12]. The non commercial compound libraries are the ones a researcher generates for him/herself of a series of molecules based on the skeleton or backbone of a molecule with known function, either biological or chemical [13-16]. These libraries tend to be smaller, in the 20-30 compounds range, and focused on one type of molecule. A library, on the other hand, which screens for an enzymatic activity, would contain structurally different molecule but each with a proven activity against a known enzyme. The larger the number of compounds used in the screening the greater the likelihood of a hit being found. Once a hit has been discovered then this molecules and those similar to item are carried through into the next phase of drug discovery



Compound Libraries: Commercial sources and types available

Commercially chemical databases are widely available in the open market ranging in price from $1200 of an 80 compound screen to $15000 for a chemical series 320 compounds. Larger or more diverse series of libraries tend to be owned by intuitions that will; for a fixed fee; run a screening of your enzymes or compounds for you.


About the Author:
We has established long-term and stable relationships with more than 10,000 customers from pharmaceutical and biotech companies, universities and research institutions. We have high quality inhibitors like Ponatinib, Entinostat, SRT1720 & more. We have headquarters in both United States and Europe



Article Originally Published On: http://www.articlesnatch.com


|

Loading...
Related....
Videos...

Recent Health Articles

Comments

Still can't find what you are looking for? Search for it!

Loading

Copyright 2005-2011 ArticleSnatch, LLC - All Rights Reserved.
Privacy Policy | Terms of Service.